Anagenics Ltd Q1 FY2027 Update
Key points
- Operating Cash Outflows improved to $0.01m vs $0.3m last quarter
- Company now trading profitably
- Royalty revenue received from YSB product line was $446k
Full summary
Anagenics Ltd (ASX:AN1) has released its Q1 FY2027 activity report, highlighting a significant improvement in operating cash outflows to $0.01 million, down from $0.3 million in the previous quarter. The improvement was driven by successful restructuring of business operations. The company is now trading profitably and expects to generate operating cash flow going forward. Royalty revenue from the YSB product line was $446,000, invoiced in June 2026. The company continues to explore value-accretive opportunities.
Guidance
Anagenics Ltd expects to generate operating cashflow going forward
Outlook
Anagenics Ltd expects to continue its profitable operations and generate operating cashflow going forward.
Summary generated by a large language model. Please interpret with care.